NCT03184363View on ClinicalTrials.gov

Efficacy and Safety of DWP450 for Treating Crows Feet Lines(CFL) in Combination With Glabellar Lines(Extension Study)

PHASE3UnknownINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

July 31, 2017

Primary Completion Date

October 31, 2017

Study Completion Date

December 31, 2017

Conditions
Crow's Feet LinesGlabellar Lines
Interventions
DRUG

Clostridium Botulinum A Toxin

Clostridium Botulinum A Toxin

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY